Transdermal Scopolamine Market: Asia Pacific to Provide Most Promising Opportunities for Growth
Researchers expect this market to remain registering exceptional growth over the forthcoming years. However, the rising reports of side-effects, such as drowsiness, retarded motion, and diluted pupils while using transdermal scopolamine patches, may limit their uptake to some extent in the near future. Apart from this, the increasing cases of adverse withdrawal symptoms for transdermal scopolamine patches and the presence of stringent laws and regulations in manufacturing and marketing of transdermal scopolamine products may hinder the market’s growth in the long run. The market, which stood at a value of US$330.0 mn in 2015, is estimated to expand at a CAGR of 6.70% from 2016 to 2024 and reach US$585.3 mn by the end of 2024.
Read Full Report: http://www.transparencymarketresearch.com/transdermal-scopolamine-market.html
Geographically, the worldwide transdermal scopolamine market is classified into Latin America, North America, the Middle East and Africa, Europe, and Asia Pacific. With a well-established healthcare industry, high healthcare expenditure, and soaring usage of transdermal scopolamine in surgeries and post-operative recovery, North America has been leading the global market.
Progressing at a CAGR of 6.40% between 2016 and 2024, the regional market is likely to retain its lead over the forthcoming years. Although transdermal scopolamine is off patent now – it was introduced in 1981 – it has very few generics available in the market, which is leading to a stagnancy in the North American market, pointing towards a moderate future growth. Europe, however, is expected to contribute significantly to the growth of the global market in the years to come. With a massive number of travelers and a state-of-art healthcare industry, Western Europe is projected to drive the Europe transdermal scopolamine market over the next few years.
Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=22322
With the increasing expenditure on healthcare, infrastructural developments in the healthcare industry, and the rising emphasis on community healthcare in emerging economies, such as China and India, Asia Pacific is expected to provide the most promising growth opportunities to players in the near future. The number of small- and medium- scale players, offering their transdermal scopolamine patches in this region, has increased substantially, making a competitive environment, which is likely to drive the Asia Pacific market for transdermal scopolamine further in the years to come. Amongst other, Latin America and the Middle East and Africa are anticipated to witness steady growth in their markets for transdermal scopolamine over the coming years, thanks to the rising number of travelers and the increasing focus of key industry players on these regions.
Baxter International Inc., GlaxoSmithKline Plc, Novartis AG, Perrigo Co. Plc, Caleb Pharmaceuticals Inc, and Myungmoon Pharma Co. Ltd. are the leading players operational in the global transdermal scopolamine market.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Transdermal Scopolamine Market: Asia Pacific to Provide Most Promising Opportunities for Growth here
News-ID: 496759 • Views: 207
More Releases from Transparency Market Research
System on Chip (SoC) Market : Dynamics, Segments and Supply Demand with Forecast …
Overview: TMR’s report on the System on Chip (SoC) Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further, undertake strategic planning for the launch of products and services. The System on Chip (SoC) Market is likely to show an optimistic CAGR of ~8.4% within a forecast period 2017 - 2025. It is expected to reach US$89.03 bn by the forecast period 2017 -
Conveyor System Market : Current Trends and Future Aspect Analysis with Forecast …
Overview: TMR’s report on the Conveyor System Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further, undertake strategic planning for the launch of products and services. The Conveyor System Market is likely to show an optimistic CAGR of ~3.5% within a forecast period 2017 - 2025. It is expected to reach US$6312.5 mn by the forecast period 2017 - 2025. Browse Our Report @
NFC Chips Market : Development Insight and Manufacturers Challenge Competitors; …
Overview: TMR’s report on the NFC Chips Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further, undertake strategic planning for the launch of products and services. The NFC Chips Market is likely to show an optimistic CAGR of ~26.0% within a forecast period 2016 - 2024. It is expected to reach US$10.62 bn by the forecast period 2016 - 2024. Browse Our Report @
Load Cell Market : Key Players and Production Information analysis with Forecast …
Overview: TMR’s report on the Load Cell Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further, undertake strategic planning for the launch of products and services. The Load Cell Market is likely to show an optimistic CAGR of ~3.50% within a forecast period 2016 - 2024. It is expected to reach US$2.55 bn by the forecast period 2016 - 2024. Browse Our Report
More Releases for Transdermal
Fentanyl Transdermal Patches Market – Comprehensive Survey 2025
This research study is one of the most detailed and accurate ones that solely focus on the global Fentanyl Transdermal Patches market. It sheds light on critical factors that impact the growth of the global Fentanyl Transdermal Patches market on several fronts. Market participants can use the report to gain sound understanding of the competitive landscape and strategies adopted by leading players of the global Fentanyl Transdermal Patches market. The
Transdermal Patch Market Report 2018: Segmentation by Product (Fentanyl Transder …
Global Transdermal Patch market research report provides company profile for Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018
Transdermal Scopolamine Market Evolution / Developments
A new study by Transparency Market Research (TMR) indicates that Novartis AG, alone, contributed nearly 41.0% of the overall revenue of the global transdermal scopolamine market in 2016. Other two torch bearers in the market, namely, GlaxoSmithKline Plc and Baxter International Inc., commanded a cumulative share of 49.0% in the same year. Even though, the number of small players in the market is less, the degree of competition within the
US Transdermal Patch Market US Transdermal Sales Report 2020
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Introduction to Transdermal Patch 2. Classification of Transdermal Patches 2.1 Single/ Multiple-Layer Drug-in-Adhesive 2.2 Reservoir Transdermal Patches 2.3 Matrix Based Transdermal Patches 2.4 Vapor Patch 2.5 Active and Passive Patch 3. Why There Exist Need for Transdermal Patches? 4. Mechanism of Transdermal Patch Drug Delivery 4.1 Properties of Transdermal Therapeutics 4.2 Components of
Transdermal Patch Market Transdermal Patch Clinical Pipeline Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents Introduction to Transdermal Patch Classification of Transdermal Patches 2.1 Single/ Multiple-Layer Drug-in-Adhesive 2.2 Reservoir Transdermal Patches 2.3 Matrix Based Transdermal Patches 2.4 Vapor Patch 2.5 Active and Passive Patch Why There Exist Need for Transdermal Patches? Mechanism of Transdermal Patch Drug Delivery 4.1 Properties of Transdermal Therapeutics 4.2 Components of Transdermal Patch 4.3
Transdermal Drug Delivery Market & Clinical Pipeline Insight
Transdermal drug delivery system, over the past decades, has emerged as a major tool for treating diseases of the skin. The major underlying factor driving this method is that the human skin is the most readily accessible surface for the delivery of drugs. A transdermal patch is defined as a medicated adhesive patch which is placed on the skin for delivering a specific dose of medication through the layers of